OUR MISSION
Clarity before certainty.
Psychedelic medicine deserves rigorous, accessible reporting—neither miracle-cure optimism nor reflexive fear. We help readers understand the evidence, the limits of that evidence, and the human questions around it.
Evidence first
Risks included
Sources linked
Uncertainty stated
WHY THIS PUBLICATION EXISTS
A calmer space for a complicated subject
Research into psychedelic-assisted therapies is developing quickly, while public discussion often moves even faster. Promising findings can become exaggerated claims; legitimate safety concerns can become stigma. Psychedelic Medicine Report exists to hold a more useful middle ground: curious, critical and humane.
01
Make research understandable
Translate studies, clinical trials and policy developments into clear language without stripping away limitations or context.
02
Reduce stigma without removing caution
Challenge misinformation and dehumanising language while discussing genuine medical, psychological, ethical and legal risks openly.
03
Support responsible discussion
Connect scientific evidence with the wider questions of patient safety, access, professional standards, regulation and ethics.
OUR EDITORIAL PRINCIPLES
The standards behind every story
Evidence over hype
We distinguish research findings from interpretation and avoid presenting early or uncertain evidence as established treatment.
Education over promotion
We explain the field; we do not tell readers how to obtain or use controlled substances, diagnose conditions or choose treatment.
Safety over sensationalism
Potential benefits are discussed alongside contraindications, adverse effects, safeguards and the realities of clinical oversight.
Compassion over stigma
Mental health reporting should be accurate and humane. We use respectful language and recognise the complexity of lived experience.
HOW WE HANDLE EVIDENCE
A transparent path from source to story
01
Start with the source
Prioritise peer-reviewed studies, trial registries and authoritative guidance.
02
Check the context
Consider study design, sample size, population, controls and conflicts of interest.
03
State the uncertainty
Make limitations and unanswered questions visible rather than hiding them in fine print.
04
Update when evidence changes
Revise material when substantial new evidence or authoritative guidance emerges.
SCOPE AND BOUNDARIES
What readers can expect from us
What we cover
- Clinical research and the strength of evidence
- Safety, risks, contraindications and safeguards
- Mental health and wider treatment context
- Ethics, regulation, access and professional standards
- Public claims, media narratives and stigma
What we do not do
- Provide diagnosis, medical advice or treatment recommendations
- Give instructions for obtaining or using controlled substances
- Promote unverified clinics, retreats or practitioners
- Present emerging findings as settled clinical fact
- Replace professional care or emergency support
CORRECTIONS AND TRANSPARENCY
Credibility includes being willing to correct the record
If we identify a factual error or significant new evidence changes the context of an article, we will correct or update it clearly. Readers are welcome to flag concerns, missing context or broken sources.
Understand the field. Keep the nuance.
Start with an accessible introduction, then explore the research and authoritative resources behind responsible discussion.
Educational information only. This website does not provide medical advice, diagnosis, treatment or guidance on the use of controlled substances. Always seek advice from a qualified healthcare professional.
Psychedelic Medicine Report 